← FDA DRUG APPROVALS

FDA ANDA · ANDA072317

ALBUTEROL SULFATE

Sponsor: PLIVA

APPLICATION
ANDA072317
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-30
LATEST ACTION
2000-07-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ALBUTEROL SULFATEDiscontinued
ALBUTEROL SULFATE EQ 4MG BASE · TABLET · ORAL

Approval history

2000-07-07Manufacturing (CMC) · Supplement 10AP
1998-05-20Labeling · Supplement 9AP
1996-08-01Manufacturing (CMC) · Supplement 8AP
1996-03-05Manufacturing (CMC) · Supplement 7AP
1995-12-22Labeling · Supplement 6AP
1994-05-17Labeling · Supplement 5AP
1994-05-17Labeling · Supplement 4AP
1994-05-11Manufacturing (CMC) · Supplement 3AP
1992-06-04Labeling · Supplement 2AP
1991-01-16Labeling · Supplement 1AP
1989-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →